# Prevention Pharmaceuticals, Inc. — Form D

Prevention Pharmaceuticals, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-11. The offering totals $2.0M, of which $650K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-01-11
- Form: D
- Accession: 0001467717-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $650K
- Remaining: $1.4M
- Minimum investment: $50K
- Investors: 5
- Date of first sale: 2010-12-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-153455

## Issuer

- Name: Prevention Pharmaceuticals, Inc.
- CIK: 0001508876
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 300 GEORGE STREET, SUITE 561, NEW HAVEN, CT, 06511
- Phone: 203-676-3676

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Scott B Kozak | Director | New Haven, CT |
| Harry H Penner, Jr. | Director | New Haven, CT |
| Rob H Sterling | Director | New Haven, CT |
| Harry H Penner, Jr. | Executive Officer | New Haven, CT |
| Terrance H Tormey | Executive Officer | New Haven, CT |

## More

- [CIK 1508876 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1508876&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001467717-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.